Medical Costs

 
News Articles for Medical Costs top ^
Molina Healthcare, Inc. (NYSE: MOH) announced today that its wholly owned subsidiary Molina Healthcare of Florida, Inc. has entered into a definitive agreement with First Coast Advantage, LLC to acquire certain assets related to First Coast Advantage’s Medicaid business.
Sign-up for Molina Healthcare Agrees to Acquire Florida Medicaid Assets from First Coast Advantage investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ; NYSE: LH) announced today the launch of Enlighten Health Genomics, a new business that builds on the diagnostic potential of Next-Generation Sequencing (NGS) technology.
Sign-up for LabCorp’s Enlighten Health Launches Innovative Genomics Initiative investment picks
- Potential Treatment of Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) in Men and Women Granted Priority Review Status - DUBLIN , Sept.
Sign-up for Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline investment picks
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced a new multi-center clinical trial has found that using St.
Sign-up for New Clinical Trial Results Demonstrate Importance of St. Jude Medical Fractional Flow Reserve in Guiding Treatment of NSTEMI Patients investment picks
NEW YORK, June 26, 2014 (GLOBE NEWSWIRE) -- AmTrust Financial Services, Inc. (Nasdaq:AFSI) ("the Company") announced today that it has agreed to acquire Comp Options Insurance Company, Inc. ("OptaComp"), an affiliated company of Blue Cross & Blue Shield of Florida ("Florida Blue"), for cash.
Sign-up for AmTrust Financial Services, Inc. to Gain Market Share With Proposed Acquisition of Comp Options Insurance Company, Inc. investment picks
-- 2014 Second Quarter Conference Call and Webcast Information Announced BUFFALO, N.Y. , July 15, 2014 /PRNewswire/ -- CTG (NASDAQ: CTG) , an information technology (IT) staffing and solutions company, today announced preliminary 2014 second quarter financial results and that it had revised its full year revenue and earnings guidance that was provided in its 2014 first quarter earnings release issued on April 22, 2014 .
Sign-up for CTG Provides Preliminary 2014 Second Quarter Results and Revises Full Year Guidance investment picks
2014/7/28
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0959514001&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg TORONTO, ONTARIO --
Sign-up for Living to 100? BMO Report Outlines What You Need To Know investment picks
2014/7/22
UnitedHealthcare’s free mobile app Health4Me is now available to all consumers.
Sign-up for UnitedHealthcare’s Free Health4Me Mobile App Now Available to Everyone investment picks
Piper Jaffray (NYSE: PJC), a leading investment bank with one of Wall Street’s most active and awarded healthcare practices, will host its Heartland Summit on August 6-7, 2014 in Minneapolis.
Sign-up for Piper Jaffray Heartland Summit Convenes Top Healthcare CEOs and Investors investment picks
2014/7/31
The U.S. business group of Sun Life Financial Inc. (NYSE: SLF, TSX: SLF) projects that New England athletes will make over 142,000 emergency room visits this year due to sports injuries, 1 nearly half experienced by athletes age 22 and younger.
Sign-up for Sun Life Financial Finds New England Sports Injuries Cause Over 142,000 Emergency Room Visits Annually – Nearly Half by Youth investment picks
Aetna (NYSE: AET ) and Banner Health Network (BHN) today announced that their accountable care collaboration resulted in a shared savings of approximately $5 million on Aetna Whole Health fully-insured commercial membership in 2013 and a five percent decline in average medical cost on the members.
Sign-up for Lower Costs, More Proactive Care in Aetna and Banner Health Network Accountable Care Collaboration investment picks
Dose Escalation Clinical Trial to Test Initial Safety and Activity of AST-OPC1 in Patient Population with the First Indication Targeted for Product Registration FDA Clearance Triggers Definitive Contract Finalization with California Institute of Regenerative Medicine (CIRM) to Begin $14.3 Million in Trial Funding MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury investment picks
Magellan Health, Inc. (NASDAQ: MGLN) today announced that Dr.
Sign-up for Magellan Health Names Dr. Karen Amstutz as Chief Medical Officer investment picks
MINNEAPOLIS , Aug.
Sign-up for Voya Financial Expands Voluntary Benefits Offering to New York State Employers investment picks
- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time - ABSORB IV will compare Absorb to a best-in-class, metallic drug eluting stent in people with coronary artery disease, the most common type of heart disease - Trial will prospectively measure rates of angina, or chest pain, in the first randomized controlled heart stent trial with angina as a primary endpoint to assess impact of angina on healthcare costs and quality of life ABBOTT PARK, Ill., Sept.
Sign-up for Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device investment picks
- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time - One-year results show Absorb provides comparable results across several measures and lower rates of angina (chest pain) than a best-in-class drug eluting stent (DES) WASHINGTON , Sept.
Sign-up for ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent investment picks
Results Suggest that Oncotype DX® Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics investment picks
Humana Inc. (NYSE: HUM) announced today that it has priced a public offering of $1.75 billion in senior notes.
Sign-up for Humana Prices $1.75 Billion Debt Offering and Intends to Complete $1 Billion of Share Repurchase by No Later Than June 2015 investment picks
Humana Inc. (NYSE: HUM) announced today that its Board of Directors has approved a $2 billion share repurchase authorization with an expiration date of December 31, 2016, replacing its previous $1 billion share repurchase authorization (of which approximately $782 million was outstanding after $118 million of share repurchases to date in the third quarter of 2014). The company may repurchase shares from time to time at prevailing prices in the open market, by block purchases, or in privately negotiated transactions (including pursuant to an accelerated share repurchase agreement with an investment bank). Cautionary Statement This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Sign-up for Humana Announces $2 Billion Share Repurchase Authorization investment picks
Humana Inc. (NYSE: HUM) announced today the completion of its public offering of $1.75 billion in senior notes.
Sign-up for Humana Completes Aggregate $1.75 Billion of Senior Notes Offerings investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Medical Costs
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Medical Care Stocks  |  Next: Medical Devices Shares